sebsebseb
2021-06-24
Up
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":121517556,"tweetId":"121517556","gmtCreate":1624475300175,"gmtModify":1634005608962,"author":{"id":3575086147705955,"idStr":"3575086147705955","authorId":3575086147705955,"authorIdStr":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Up</p></body></html>","htmlText":"<html><head></head><body><p>Up</p></body></html>","text":"Up","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/121517556","repostId":2145301867,"repostType":2,"repost":{"id":"2145301867","kind":"news","pubTimestamp":1624463100,"share":"https://www.laohu8.com/m/news/2145301867?lang=&edition=full","pubTime":"2021-06-23 23:45","market":"us","language":"en","title":"The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN","url":"https://stock-news.laohu8.com/highlight/detail?id=2145301867","media":"ACCESSWIRE","summary":"NEW YORK, NY / ACCESSWIRE / June 23, 2021 / The securities litigation law firm of The Gross Law Firm","content":"<html><body><p><strong>NEW YORK, NY / ACCESSWIRE / June 23, 2021 /</strong> The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.</p>\n<p><strong><a href=\"https://laohu8.com/S/CCIV\">Churchill Capital Corp IV</a> (NYSE:CCIV)</strong></p>\n<p><strong>Investors Affected : January 11, 2021 - February 22, 2021</strong></p>\n<p>A class action has commenced on behalf of certain shareholders in <a href=\"https://laohu8.com/S/CCIV.U\">Churchill Capital Corp IV</a>. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>\n<p>Shareholders may find more information at https://securitiesclasslaw.com/securities/churchill-capital-corp-iv-loss-submission-form/?id=17122&from=1</p>\n<p><strong><a href=\"https://laohu8.com/S/FREQ\">Frequency Therapeutics, Inc.</a> (NASDAQ:FREQ)</strong></p>\n<p><strong>Investors Affected : November 16, 2020 - March 22, 2021</strong></p>\n<p>A class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.</p>\n<p>Shareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17122&from=1</p>\n<p><strong>Ocugen, Inc. (NASDAQ:OCGN)</strong></p>\n<p><strong>Investors Affected : February 2, 2021 - June 10, 2021</strong></p>\n<p>A class action has commenced on behalf of certain shareholders in Ocugen, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.</p>\n<p>Shareholders may find more information at https://securitiesclasslaw.com/securities/ocugen-inc-loss-submission-form/?id=17122&from=1</p>\n<img src=\"https://s1.yimg.com/uu/api/res/1.2/DkCIlqsg_59barbKGDUmCA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/accesswire.ca/f6be8399165579e8bdfa12794c467eb2\"/>\n<p>The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.</p>\n<p><strong>CONTACT:</strong><br/>The Gross Law Firm<br/>15 West 38th Street, 12th floor<br/>New York, NY, 10018<br/>Email: dg@securitiesclasslaw.com<br/>Phone: (212) 537-9430<br/>Fax: (833) 862-7770</p>\n<p><strong>SOURCE: </strong>The Gross Law Firm</p>\n<br/>\n<br/>View source version on accesswire.com: \n<br/>\nhttps://www.accesswire.com/652845/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-FREQ-and-OCGN\n<br/>\n<br/>\n<img height=\"0\" src=\"https://www.accesswire.com/img.ashx?id=652845\" width=\"0\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of CCIV, FREQ and OCGN\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 23:45 GMT+8 <a href=https://finance.yahoo.com/news/gross-law-firm-announces-class-154500273.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, NY / ACCESSWIRE / June 23, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/gross-law-firm-announces-class-154500273.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/lbmg.m0FIEdY8ggrXpil3A--~B/aD0zMDc7dz0zMDc7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Cz__YWM.PoHWdcBBOe1T7g--~B/aD0zMDc7dz0zMDc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/f6be8399165579e8bdfa12794c467eb2","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://finance.yahoo.com/news/gross-law-firm-announces-class-154500273.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145301867","content_text":"NEW YORK, NY / ACCESSWIRE / June 23, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.\nChurchill Capital Corp IV (NYSE:CCIV)\nInvestors Affected : January 11, 2021 - February 22, 2021\nA class action has commenced on behalf of certain shareholders in Churchill Capital Corp IV. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting a production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.\nShareholders may find more information at https://securitiesclasslaw.com/securities/churchill-capital-corp-iv-loss-submission-form/?id=17122&from=1\nFrequency Therapeutics, Inc. (NASDAQ:FREQ)\nInvestors Affected : November 16, 2020 - March 22, 2021\nA class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.\nShareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17122&from=1\nOcugen, Inc. (NASDAQ:OCGN)\nInvestors Affected : February 2, 2021 - June 10, 2021\nA class action has commenced on behalf of certain shareholders in Ocugen, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.\nShareholders may find more information at https://securitiesclasslaw.com/securities/ocugen-inc-loss-submission-form/?id=17122&from=1\n\nThe Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.\nCONTACT:The Gross Law Firm15 West 38th Street, 12th floorNew York, NY, 10018Email: dg@securitiesclasslaw.comPhone: (212) 537-9430Fax: (833) 862-7770\nSOURCE: The Gross Law Firm\n\nView source version on accesswire.com: \n\nhttps://www.accesswire.com/652845/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CCIV-FREQ-and-OCGN","news_type":1},"isVote":1,"tweetType":1,"viewCount":146,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/121517556"}
精彩评论